Cincinnati--Michael Thomas, MD, Professor of Obstetrics and
Gynecology, UC College of Medicine,and co-director of the UC Center for
Reproductive Medicine Research, has received a $421,000 grant from the
National Institutes of Health (NIH) to study a new spermicide. The
purpose of this study is to compare a new spermicide with an
over-the-counter spermicide. The spermicides will be used with a
diaphragm and the products will be compared for effectiveness and side
Participants will be required to use this as their
primary method of birth control. The nationwide study will involve 975
female subjects. Study participation will last six menstrual cycles or
approximately seven months. Women in this clinical trial will be 18 to
40 years old, with no known allergy or sensitivity to spermicide gels
or products containing latex. Women cannot participate in this research
if they have used Depo-Provera in the past ten months, are pregnant or
breast-feeding. Women should be generally healthy and not diagnosed
with sexually transmitted diseases in the previous six months.
Participants will be compensated for their time.
For more information or to see if you qualify for this study, please call (513) 584-4100.